NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球乳癌診斷市場分析(2021年):新型冠狀病毒感染疾病(COVID-19)造成的成長和變化(到2030年)

Breast Cancer Diagnostics Global Market Report 2021: COVID 19 Growth And Change to 2030

出版商 The Business Research Company 商品編碼 1004019
出版日期 按訂單生產 內容資訊 英文 175 Pages
商品交期: 2-10個工作天內
價格
全球乳癌診斷市場分析(2021年):新型冠狀病毒感染疾病(COVID-19)造成的成長和變化(到2030年) Breast Cancer Diagnostics Global Market Report 2021: COVID 19 Growth And Change to 2030
出版日期: 按訂單生產內容資訊: 英文 175 Pages
簡介

本報告提供全球乳癌診斷市場相關調查,提供市場概要,各市場區隔的市場規模的變化與預測,新型冠狀病毒感染疾病(COVID-19)的對市場的影響,市場成長的推動要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場趨勢與策略

第4章 新型冠狀病毒感染疾病(COVID-19)的影響

第5章 市場規模與成長

  • 全球乳癌診斷市場(實際成果值)
    • 市場推動要素
    • 市場阻礙因素
  • 全球乳癌診斷市場(預測值)
    • 市場推動要素
    • 市場阻礙因素

第6章 乳癌診斷市場:各市場區隔

  • 市場區隔:各類型(實際成果值·預測值)
    • 成像
    • 切片檢查
    • 遺傳基因檢驗
    • 血液檢驗
    • 其他
  • 市場區隔:各技術(實際成果值·預測值)
    • 螢光原位雜合技術(FISH)
    • 比較基因雜合反應(CGH)
    • 免疫組織化學(IHC)
    • 其他
  • 市場區隔:各子類型(實際成果值·預測值)
    • BRCA
    • ER & PR
    • HER2
    • EGFR
    • 其他
  • 市場區隔:各終端用戶(實際成果值·預測值)
    • 醫院·診療所
    • 癌症研究中心
    • 診斷實驗室
    • 門診外科中心

第7章 乳癌診斷市場:各地各國

  • 市場規模:各地區(實際成果值·預測值)
  • 市場規模:各國(實際成果值·預測值)

第8章 亞太地區的乳癌診斷市場

  • 市場概要
  • 地區/市場資訊·COVID-19的影響·政府措施·規定·公司稅結構·投資·主要企業等
  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第9章 中國的乳癌診斷市場

  • 市場概要
  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第10章 印度的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第11章 日本的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第12章 澳洲的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第13章 印尼的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第14章 韓國的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第15章 西歐的乳癌診斷市場

  • 市場概要
  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第16章 英國的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第17章 德國的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第18章 法國的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第19章 東歐的乳癌診斷市場

  • 市場概要
  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第20章 俄羅斯的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第21章 北美的乳癌診斷市場

  • 市場概要
  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第22章 美國的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第23章 南美的乳癌診斷市場

  • 市場概要
  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第24章 巴西的乳癌診斷市場

  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第25章 中東的乳癌診斷市場

  • 市場概要
  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第26章 非洲的乳癌診斷市場

  • 市場概要
  • 市場規模:各類型(實際成果值·預測值)
  • 市場規模:各終端用戶(實際成果值·預測值)

第27章 競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Abbott Laboratories
    • Myriad Genetics Inc
    • Hologic Inc
    • Koninklijke Philips N.V.
    • Fujifilm Holdings Corporation

第28章 主要合併·收購

第29章 未來預測與潛在性分析

第30章 附錄

目錄

Breast Cancer Diagnostics Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global breast cancer diagnostics market.

This report focuses on breast cancer diagnostics market which is experiencing strong growth. The report gives a guide to the breast cancer diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the breast cancer diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Breast Cancer Diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider breast cancer diagnostics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The breast cancer diagnostics market section of the report gives context. It compares the breast cancer diagnostics market with other segments of the breast cancer diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, breast cancer diagnostics indicators comparison.

Scope

Markets Covered:1)By Type: Imaging; Biopsy; Genomic Tests; Blood Tests; Others 2) By Technology: Fluorescent In Situ Hybridization (FISH); Comparative Genomic Hybridization (CGH); Immunohistochemical (IHC); Other Technologies 3) By Cancer Type: BRCA Breast Cancer; ER & PR Breast Cancer; HER 2 Breast Cancer; EGFR Mutation Test Breast Cancer; Others 4) By Diagnostic Type: Ionizing Breast Imaging Technologies; Non-ionizing Imaging Technologies 5) By End Users: Hospitals and Clinics; Cancer Research Centers; Diagnostic Laboratories; Ambulatory Surgical Centers

Companies Mentioned:Abbott Laboratories; Myriad Genetics, Inc.; Hologic, Inc.; Koninklijke Philips N.V.; Fujifilm Holdings Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Breast Cancer Diagnostics Market Characteristics

3. Breast Cancer Diagnostics Market Trends And Strategies

4. Impact Of COVID-19 On Breast Cancer Diagnostics

5. Breast Cancer Diagnostics Market Size And Growth

  • 5.1. Global Breast Cancer Diagnostics Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Breast Cancer Diagnostics Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Breast Cancer Diagnostics Market Segmentation

  • 6.1. Global Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Imaging
  • Biopsy
  • Genomic Tests
  • Blood Tests
  • Others
  • 6.2. Global Breast Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Fluorescent In Situ Hybridization (FISH)
  • Comparative Genomic Hybridization (CGH)
  • Immunohistochemical (IHC)
  • Other Technologies
  • 6.3. Global Breast Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • BRCA Breast Cancer
  • ER & PR Breast Cancer
  • HER 2 Breast Cancer
  • EGFR Mutation Test Breast Cancer
  • Others
  • 6.4. Global Breast Cancer Diagnostics Market, Segmentation By Diagnostic Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Ionizing Breast Imaging Technologies
  • Non-ionizing Imaging Technologies
  • 6.5. Global Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals and Clinics
  • Cancer Research Centers
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers

7. Breast Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global Breast Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Breast Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Breast Cancer Diagnostics Market

  • 8.1. Asia-Pacific Breast Cancer Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Breast Cancer Diagnostics Market

  • 9.1. China Breast Cancer Diagnostics Market Overview
  • 9.2. China Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Breast Cancer Diagnostics Market

  • 10.1. India Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Breast Cancer Diagnostics Market

  • 11.1. Japan Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Breast Cancer Diagnostics Market

  • 12.1. Australia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Breast Cancer Diagnostics Market

  • 13.1. Indonesia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Breast Cancer Diagnostics Market

  • 14.1. South Korea Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Breast Cancer Diagnostics Market

  • 15.1. Western Europe Breast Cancer Diagnostics Market Overview
  • 15.2. Western Europe Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Breast Cancer Diagnostics Market

  • 16.1. UK Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Breast Cancer Diagnostics Market

  • 17.1. Germany Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Breast Cancer Diagnostics Market

  • 18.4. France Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Breast Cancer Diagnostics Market

  • 19.1. Eastern Europe Breast Cancer Diagnostics Market Overview
  • 19.2. Eastern Europe Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Breast Cancer Diagnostics Market

  • 20.1. Russia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Breast Cancer Diagnostics Market

  • 21.1. North America Breast Cancer Diagnostics Market Overview
  • 21.2. North America Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Breast Cancer Diagnostics Market

  • 22.1. USA Breast Cancer Diagnostics Market Overview
  • 22.2. USA Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Breast Cancer Diagnostics Market

  • 23.1. South America Breast Cancer Diagnostics Market Overview
  • 23.2. South America Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Breast Cancer Diagnostics Market

  • 24.1. Brazil Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Breast Cancer Diagnostics Market

  • 25.1. Middle East Breast Cancer Diagnostics Market Overview
  • 25.2. Middle East Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Breast Cancer Diagnostics Market

  • 26.1. Africa Breast Cancer Diagnostics Market Overview
  • 26.2. Africa Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Breast Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 27.1. Breast Cancer Diagnostics Market Competitive Landscape
  • 27.2. Breast Cancer Diagnostics Market Company Profiles
    • 27.2.1. Abbott Laboratories
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Myriad Genetics Inc
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Hologic Inc
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Koninklijke Philips N.V.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Fujifilm Holdings Corporation
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Breast Cancer Diagnostics Market

29. Breast Cancer Diagnostics Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer